Correlation Between BIONTECH and UBS Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BIONTECH and UBS Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BIONTECH and UBS Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BIONTECH SE DRN and UBS Group AG, you can compare the effects of market volatilities on BIONTECH and UBS Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BIONTECH with a short position of UBS Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of BIONTECH and UBS Group.

Diversification Opportunities for BIONTECH and UBS Group

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between BIONTECH and UBS is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding BIONTECH SE DRN and UBS Group AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UBS Group AG and BIONTECH is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BIONTECH SE DRN are associated (or correlated) with UBS Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UBS Group AG has no effect on the direction of BIONTECH i.e., BIONTECH and UBS Group go up and down completely randomly.

Pair Corralation between BIONTECH and UBS Group

Assuming the 90 days trading horizon BIONTECH is expected to generate 1.0 times less return on investment than UBS Group. In addition to that, BIONTECH is 1.86 times more volatile than UBS Group AG. It trades about 0.07 of its total potential returns per unit of risk. UBS Group AG is currently generating about 0.13 per unit of volatility. If you would invest  16,810  in UBS Group AG on September 28, 2024 and sell it today you would earn a total of  1,928  from holding UBS Group AG or generate 11.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

BIONTECH SE DRN  vs.  UBS Group AG

 Performance 
       Timeline  
BIONTECH SE DRN 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BIONTECH SE DRN are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, BIONTECH may actually be approaching a critical reversion point that can send shares even higher in January 2025.
UBS Group AG 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in UBS Group AG are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, UBS Group may actually be approaching a critical reversion point that can send shares even higher in January 2025.

BIONTECH and UBS Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BIONTECH and UBS Group

The main advantage of trading using opposite BIONTECH and UBS Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BIONTECH position performs unexpectedly, UBS Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UBS Group will offset losses from the drop in UBS Group's long position.
The idea behind BIONTECH SE DRN and UBS Group AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data